01:48 , Sep 24, 2015 |  BC Extra  |  Company News

Management tracks

Drug delivery play leon-nanodrugs GmbH (Munich, Germany) named Theron Odlaug CEO. Odlaug was executive chairman at Cedarburg Hauser Pharmaceuticals Inc. , which Albany Molecular Research Inc. (NASDAQ:AMRI) acquired. Peptide company Bicycle Therapeutics Ltd. (Cambridge, U.K.)...
07:00 , Apr 14, 2014 |  BC Week In Review  |  Company News

Albany Molecular Research, Cedarburg Hauser deal

Albany Molecular completed its acquisition of contract developer and manufacturer Cedarburg for $41 million in cash, including assumption of liabilities (see BioCentury, March 31). Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y.   Cedarburg Hauser Pharmaceuticals...
07:00 , Mar 31, 2014 |  BC Week In Review  |  Company News

Albany Molecular Research, Cedarburg Hauser deal

Albany Molecular will acquire contract developer and manufacturer Cedarburg for $38.2 million in cash. Cedarburg's core capabilities include the production of controlled substances, prostaglandins, vitamin D analogs, conjugation chemistry and inorganics for analgesic, ophthalmic and...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Company News

Cedarburg Hauser management update

Cedarburg Hauser Pharmaceuticals Inc. , Grafton, Wis.   Business: Supply/Service, Biomanufacturing   Promoted: John Lynch to CSO from director of R&D  ...